Stocks in this week’s article are IPG Photonics IPGP, Dollar General DG, Ironwood Pharmaceuticals IRWD and Science ...
The pharmaceutical sector is famously volatile, usually driven by the binary outcomes of clinical trials. A drug either works, sending the stock to the moon, or it fails, causing a crash. However, ...
Zacks Investment Research on MSN
4 stocks trading near 52-week high with more upside potential
Investors generally consider a stock's 52-week high a good criterion for an entry or exit point. Stocks touching new 52-week highs are often predisposed to profit-taking, resulting in pullbacks and ...
After a sluggish first half, the drug and biotech sector has staged a recovery over the past two to three months. This rebound was supported by major drugmakers signing drug pricing agreements with ...
Year Diluted EPS of $2.36 on a GAAP Basis, a Decrease of 1.3 Percent; Adjusted Diluted EPS of $10.00, a Decrease of 1.2 Percent; These Results Include an Unfavorable ...
They’re harnessing it to help directors prepare, debate, and decide. by Stanislav Shekshnia and Valery Yakubovich In 2014 Hong Kong–based Deep Knowledge Ventures formally appointed an algorithm to its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results